Wells Fargo & Company Third Harmonic Bio, Inc. Call Options Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

Call Options

0 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form

No transaction found.

Others Institutions Holding THRD

# of Institutions

83

Shares Held

43.6M

Call Options Held

7.1K

Put Options Held

0

Atlas Venture Life Science Advisors, LLC

10.9M
Shares

$113 Million
18.24% of portfolio
Orbimed Advisors LLC San Diego, CA

5.78M
Shares

$59.6 Million
1.85% of portfolio
Bvf Inc San Francisco, CA

4.37M
Shares

$45.1 Million
1.88% of portfolio
Eco R1 Capital, LLC San Francisco, CA

3.18M
Shares

$32.8 Million
1.87% of portfolio
General Atlantic LLC New York, NY

2.96M
Shares

$30.5 Million
1.15% of portfolio

About Third Harmonic Bio, Inc.

Ticker THRD
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,328,900
Market Cap $416M

More about THRD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.